Deletion of IL-4 Receptor Alpha on B Lymphocytes renders BALB/c Mice balance Th differentiation to Leishmania major Infection during the early stage of Infection.

B-lymphocytes are considered to play a minimal role in host defense against Leishmania major. In BALB/c mice, susceptibility to infection with the intracellular parasite Leishmania major is driven largely by the development of T helper 2 (Th2) responses and the production of interleukin (IL-4 and IL-13), which share a common receptor subunit, the IL-4 receptor alpha chain (IL-4Rα). To investigate the relevance IL-4Rα mediated signalling in B Lymphocytes independently of non-B cells during the early stage in vivo infection, B-lymphocytes specific IL-4Rα deficient (MB-1-hCreIL4Rα -/LOX ) BALB/c mice were generated by gene targeting and site-specific recombination using the cre/loxP system under control of the MB-1 locus. DNA functional characterization through RT-PCR showed a balanced IL-4Rα expression on B-lymphocytes in MB-1-hCre IL4Rα -/LOX mice. We conclude from these data that the balanced expression shows that the Th differentiation doesn’t happen in the early stage of infection and considered this an important host protective factor during early infection of cutaneous leishmaniasis.

[1]  J. Berman,et al.  Advances in leishmaniasis , 2005, The Lancet.

[2]  D. Sacks,et al.  The immunology of susceptibility and resistance to Leishmania major in mice , 2002, Nature Reviews Immunology.

[3]  G. Köhler,et al.  Differences between IL-4- and IL-4 receptor alpha-deficient mice in chronic leishmaniasis reveal a protective role for IL-13 receptor signaling. , 1999, Journal of immunology.

[4]  D. Brown,et al.  Polarized Helper-T-Cell Responses againstLeishmania major in the Absence of B Cells , 1999, Infection and Immunity.

[5]  C. Bogdan,et al.  Tissue expression of inducible nitric oxide synthase is closely associated with resistance to Leishmania major , 1994, The Journal of experimental medicine.

[6]  A. Hoerauf,et al.  The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. , 1994, International immunology.

[7]  H. Winn,et al.  Immunologically nonspecific mechanisms of tissue destruction in the rejection of skin grafts , 1994, The Journal of experimental medicine.

[8]  R. Rerko,et al.  Recombinant interleukin 12 cures mice infected with Leishmania major , 1993, The Journal of experimental medicine.

[9]  I. Müller,et al.  TH1 and TH2 T-cell subsets are differentially activated by macrophages and B cells in murine leishmaniasis , 1993, Infection and immunity.

[10]  A. Kelso,et al.  Changes in the precursor frequencies of IL-4 and IFN-gamma secreting CD4+ cells correlate with resolution of lesions in murine cutaneous leishmaniasis. , 1992, Journal of immunology.

[11]  P. Scott,et al.  Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway. , 1984, Journal of immunology.